Sodium Hydroxide → (E)-5-(3,4-dichlorostyryl)-2,3-dihydro-1H-1,4-benzodiazepine-1-acetic acid

HRID 48351ノート

反応式

HRID 48351 の反応式
[OH-].[Na+].[Cl:3][C:4]1[CH:5]=[C:6]([CH:26]=[CH:27][C:28]=1[Cl:29])[CH:7]=[CH:8][C:9]1=[N:10][CH2:11][CH2:12][N:13]([CH2:20][C:21]([O:23]CC)=[O:22])[C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]1=2>C(O)C>[Cl:3][C:4]1[CH:5]=[C:6]([CH:26]=[CH:27][C:28]=1[Cl:29])[CH:7]=[CH:8][C:9]1=[N:10][CH2:11][CH2:12][N:13]([CH2:20][C:21]([OH:23])=[O:22])[C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]1=2

参加物

4

実験手順

0.5 ml of 1M sodium hydroxide solution were added to a solution of 113 mg (0.28 mmol) of ethyl (E)-2-[5-(3,4-dichlorostyryl)-2,3-dihydro-1,4-benzodiazepin-1-yl]acetate in 3 ml of ethanol and the mixture left at room temperature for 1.5 hours. The solvent was removed by evaporation and the residue dissolved in water and washed with diethyl ether. The aqueous layer was acidified with acetic acid and a red gum separated out. The gum was dissolved in a small amount of ethanol and diluted with ethyl acetate and washed with water. The organic phase was dried over magnesium sulphate, filtered and evaporated to dryness to give 88 mg of (E)-5-(3,4-dichlorostyryl)-2,3-dihydro-1H-1,4-benzodiazepine-1-acetic acid as a red solid. MS: m/e 374.9 [M+H]+.

後処理

  1. customThe solvent was removed by evaporation
  2. dissolutionthe residue dissolved in water
  3. washwashed with diethyl ether
  4. customa red gum separated out
  5. dissolutionThe gum was dissolved in a small amount of ethanol
  6. additiondiluted with ethyl acetate
  7. washwashed with water
  8. dry with materialThe organic phase was dried over magnesium sulphate
  9. filtrationfiltered
  10. customevaporated to dryness

出典と根拠

ORDレコード
ord-363cbce40e864b21981a7c63838d8f75
出典データセット
uspto-grants-2004_03
特許番号
US06703387B2

反応ノート

読み込み中…